{"id":"W2152727843","doi":"10.1056/nejmoa0809335","title":"A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":891,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"UCB Pharma; Technion-Israel Institute of Technology; Eisai; H. Lundbeck A/S; Teva Pharmaceutical Industries; AstraZeneca","keywords":"Rasagiline; Medicine; Placebo; Parkinson's disease; Rating scale; Clinical trial; Internal medicine; Disease; Psychology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001525493,0.001538463,0.002758983,0.0003929587,0.000388402,0.000622493,0.0008355742,0.001687051,0.004899783],"category_scores_gemma":[0.001215628,0.0004707205,0.001039402,0.0002969865,0.0007761217,0.000686631,0.0003284484,0.001926719,0.0007990413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003969489,"about_ca_system_score_gemma":0.001021886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004391288,"about_ca_topic_score_gemma":0.001075619,"domain_scores_codex":[0.999492,0.0002603339,0.00004027428,0.00009227177,0.00004992493,0.00006512886],"domain_scores_gemma":[0.9989725,0.0002948593,0.0002071807,0.0000912527,0.00009548073,0.0003386145],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9714624,0.008040559,0.0002562036,0.0005619857,0.0002472503,0.00003840023,0.0000342448,0.0001769155,0.004429464,0.00005274289,0.0004127724,0.01428703],"study_design_scores_gemma":[0.8936252,0.10397,0.001036365,0.00002459164,0.0001354816,0.00004325972,0.000008989943,0.0001829411,0.0006203084,0.0000500637,0.0002946979,0.000008157817],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990594,0.004428613,0.0004159251,0.0002402177,0.0003520501,0.001997488,0.0005743652,0.0001063145,0.001291095],"genre_scores_gemma":[0.9875651,0.002473086,0.002076906,0.0005107464,0.0004020825,0.003641314,0.0007252798,0.00002156064,0.002583959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004899783,"threshold_uncertainty_score":0.01639134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03841160269892531,"score_gpt":0.3158439581302381,"score_spread":0.2774323554313128,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}